Prognosis
New Astra Vaccine in Development to Fight South Africa Variant
- Oxford professor says adapted shot should be ready by autumn
- Study showed dose less effective against South African strain
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Vaccine developers said they are working on a new shot to combat the South African strain of coronavirus after early data suggested AstraZeneca Plc’s product has limited efficacy against mild disease caused by the variant.